Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases

E-ISSN： 2212-3873|6|1|33-43

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.1, 2006-03, pp. : 33-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-06 ,pp. : 728-749

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparative Study on Selective PPAR Modulators through Quantitative Structure-activity Relationship, Pharmacophore and Docking Analyses

Current Computer - Aided Drug Design, Vol. 14, Iss. 1, 2018-03 ,pp. : 54-67

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Sirtuin Modulators: Targets for Metabolic Diseases and Beyond

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-11 ,pp. : 1533-1544

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)

By Lamers Christina Schubert-Zsilavecz Manfred Merk Daniel

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 803-841

Informa Healthcare

Access to resources Recommend Favorite